Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Serum lipidomic study of long-chain fatty acids in psoriasis patients prior to and after anti-IL-17A monoclonal antibody treatment by quantitative GC‒MS analysis with in situ extraction

Fig. 3

Anti-IL-17A mAb regulated abnormal LCFA metabolism in psoriasis patients. The total LCFA (a), SFAs (b, e), MUFA (c, f) and PUFA (d, g) contents in the serum samples of healthy individuals and psoriasis patients receiving pretherapy and posttreatment with anti-IL-17A mAb. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X